Ризедронат Тева 35 мг

Šalis: Izraelis

kalba: rusų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

RISEDRONIC ACID AS SODIUM 35 MG

Prieinama:

ABIC MARKETING LTD

ATC kodas:

M05BA07

Vaisto forma:

TABLETS

Vartojimo būdas:

PER OS

Pagaminta:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Farmakoterapinė grupė:

RISEDRONIC ACID

Terapinės indikacijos:

Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.

Leidimo data:

2011-10-01